Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)
Clinical trial NCT00687219 · COMPLETED
Trial details
- NCT number
- NCT00687219
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2010-10-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.